Daniel Jacoby
Daniel Jacoby
Verified email at yale.edu
Title
Cited by
Cited by
Year
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)
MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ...
Journal of the American College of Cardiology 68 (2), 161-172, 2016
2072016
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ...
Circulation 138 (14), 1387-1398, 2018
1992018
Genetics of inherited cardiomyopathy
D Jacoby, WJ McKenna
European heart journal 33 (3), 296-304, 2012
1672012
Update on hypertrophic cardiomyopathy and a guide to the guidelines
S Sen-Chowdhry, D Jacoby, JC Moon, WJ McKenna
Nature Reviews Cardiology 13 (11), 651-675, 2016
1062016
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ...
The Lancet 396 (10253), 759-769, 2020
892020
Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy
DP Judge, SB Heitner, RH Falk, MS Maurer, SJ Shah, RM Witteles, ...
Journal of the American College of Cardiology 74 (3), 285-295, 2019
892019
Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial
SB Heitner, D Jacoby, SJ Lester, A Owens, A Wang, D Zhang, J Lambing, ...
Annals of internal medicine 170 (11), 741-748, 2019
712019
Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure
JM Testani, JS Hanberg, S Cheng, V Rao, C Onyebeke, O Laur, A Kula, ...
Circulation: Heart Failure 9 (1), e002370, 2016
702016
Empagliflozin in heart failure: diuretic and cardiorenal effects
M Griffin, VS Rao, J Ivey-Miranda, J Fleming, D Mahoney, C Maulion, ...
Circulation 142 (11), 1028-1039, 2020
692020
Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink
A Kaoukis, V Panagopoulou, HR Mojibian, D Jacoby
Circulation 125 (12), 1584-1585, 2012
682012
Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment
JM Testani, MA Brisco, RD Kociol, D Jacoby, L Bellumkonda, CR Parikh, ...
The American journal of medicine 128 (7), 776-783. e4, 2015
612015
Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure
JM Testani, JS Hanberg, JP Arroyo, MA Brisco, JM Ter Maaten, FP Wilson, ...
European journal of heart failure 18 (6), 660-668, 2016
552016
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
R Walsh, F Mazzarotto, N Whiffin, R Buchan, W Midwinter, A Wilk, N Li, ...
Genome medicine 11 (1), 1-18, 2019
532019
Outcomes of adults with restrictive cardiomyopathy after heart transplantation
EC DePasquale, K Nasir, DL Jacoby
The Journal of heart and lung transplantation 31 (12), 1269-1275, 2012
532012
Anisotropic engineered heart tissue made from laser-cut decellularized myocardium
J Schwan, AT Kwaczala, TJ Ryan, O Bartulos, Y Ren, LR Sewanan, ...
Scientific reports 6 (1), 1-12, 2016
522016
Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction
S Angraal, BJ Mortazavi, A Gupta, R Khera, T Ahmad, NR Desai, ...
JACC: Heart Failure 8 (1), 12-21, 2020
492020
Compensatory distal reabsorption drives diuretic resistance in human heart failure
VS Rao, N Planavsky, JS Hanberg, T Ahmad, MA Brisco-Bacik, FP Wilson, ...
Journal of the American Society of Nephrology 28 (11), 3414-3424, 2017
492017
Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy
CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ...
Journal of the American College of Cardiology 75 (21), 2649-2660, 2020
462020
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy
ED Smith, NK Lakdawala, N Papoutsidakis, G Aubert, A Mazzanti, ...
Circulation 141 (23), 1872-1884, 2020
452020
Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, ...
Circulation 141 (10), 828-842, 2020
432020
The system can't perform the operation now. Try again later.
Articles 1–20